View of Non-pegylated liposomal doxorubicin plus capecitabine as first-line treatment in metastatic breast cancer

Return to Article Details Non-pegylated liposomal doxorubicin plus capecitabine as first-line treatment in metastatic breast cancer Download Download PDF